Search

James Kurnick

from Needham, MA
Get Report
Connected to:
George J Kurnick, 66James T Kurnick, 77John E Kurnick, 83Nathaniel B Kurnick, 107Betsy S Kurnik, 53Jessica W Kurnik, 42Bryan R Kurnoff, 35Rachel S Kurnos, 38Lisa Kurnosoff, 55David Kurnov, 41

James Kurnick Phones & Addresses

  • Needham, MA

Work

Company: Massachusetts General Hosp Path Address: 55 Fruit St Suite 2, Boston, MA 02114 Phones: (617) 726-2967

Education

School / High School: Tufts University 1973

Languages

English

Specialities

Allergy & Immunology • Anatomic & Clinical Pathology • Immunology

Professional Records

Medicine Doctors

James Kurnick Photo 1

Dr. James T Kurnick, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Allergy & Immunology
Anatomic & Clinical Pathology
Immunology
Address:
Massachusetts General Hosp Path
55 Fruit St Suite 2, Boston, MA 02114
(617) 726-2967 (Phone)
Languages:
English
Hospitals:
Massachusetts General Hosp Path
55 Fruit St Suite 2, Boston, MA 02114

Massachusetts General Hospital
55 Fruit Street, Boston, MA 02114
Education:
Medical School
Tufts University
Graduated: 1973
Medical School
University Colorado Med Center
Graduated: 1973
Medical School
Uppsala University Sweden
Graduated: 1973
James Kurnick Photo 2

James Thomas Kurnick

View page
Specialties:
Pathology
Anatomic Pathology
Allergy & Immunology
Clinical & Laboratory Immunology
Education:
Tufts University (1973)
James Kurnick Photo 3

James T Kurnick, Beverly MA

View page
Specialties:
Pathologist
Address:
100 Cummings Ctr, Beverly, MA 01915

Business Records

Name / Title
Company / Classification
Phones & Addresses
James Thomas Kurnick
James Kurnick MD
55 Fruit St, Boston, MA 02114
(617) 726-5690
James Kurnick
Owner, Managing
Cytocure Llc
Biotechnology · Mfg Biological Products
100 Cummings Ctr, Beverly, MA 01915
(978) 232-1243

Publications

Us Patents

Outer Membrane Protein A, Peptidoglycan-Associated Lipoprotein, And Murein Lipoprotein As Therapeutic Targets For Treatment Of Sepsis

View page
US Patent:
20030017162, Jan 23, 2003
Filed:
Mar 13, 2002
Appl. No.:
10/097538
Inventors:
H. Warren - Charlestown MA, US
Judith Hellman - Brookline MA, US
James Kurnick - Winchester MA, US
International Classification:
A61K039/40
A61K039/02
US Classification:
424/164100, 424/190100
Abstract:
The present invention relates to three outer membrane proteins conserved among Gram-negative bacteria, OmpA, PAL, and MLP. The invention provides vaccines and polypeptides useful for passive and active immunization against Gram-negative bacteria, as well as methods of preventing and treating Gram-negative sepsis.

Methods For Up-Regualting Antigen Expression Of Tumors

View page
US Patent:
20040253235, Dec 16, 2004
Filed:
Aug 29, 2003
Appl. No.:
10/651616
Inventors:
Paul Durda - Needham MA, US
James Kurnick - Winchester MA, US
Ian Dunn - Sydney, AU
International Classification:
A61K039/395
US Classification:
424/143100
Abstract:
The invention provides methods of modulating tumor antigen associated (TAA) expression, and methods of modulating TAA expression in order to treat a tumor. More particularly, the invention provides methods of increasing an immune response against a tumor cell. Methods include administering to a subject with a tumor an amount of IFN- receptor agonist and tumor associated antigen (TAA) sufficient to increase an immune response against the tumor cell.

Methods For Up-Regulating Antigen Expression In Tumors

View page
US Patent:
20120195855, Aug 2, 2012
Filed:
Oct 19, 2011
Appl. No.:
13/276783
Inventors:
Paul J. Durda - Needham MA, US
James T. Kurnick - Quincy MA, US
Ian S. Dunn - Sydney, AU
Assignee:
CytoCure LLC - Beverly MA
International Classification:
A61K 38/21
A61P 35/04
A61P 35/00
US Classification:
424 856
Abstract:
The invention provides methods of modulating tumor antigen associated (TAA) expression, and methods of modulating TAA expression in order to treat a tumor. More particularly, the invention provides methods of increasing an immune response against a tumor cell. Methods include administering to a subject with a tumor an amount of IFN-β receptor agonist and tumor associated antigen (TAA) sufficient to increase an immune response against the tumor cell.

Methods, Compositions, And Kits For The Treatment Of Cancer

View page
US Patent:
20140335050, Nov 13, 2014
Filed:
May 25, 2012
Appl. No.:
14/122531
Inventors:
Timothy J. Haggerty - Concord MA, US
James T. Kurnick - Quincy MA, US
Ian S. Dunn - Sydney, AU
Assignee:
The General Hospital Corporation - Boston MA
CytoCure LLC - Beverly MA
International Classification:
A61K 35/14
A61K 31/4965
A61K 45/06
A61K 38/21
A61K 39/395
US Classification:
424 855, 424 856, 4241581, 4241741, 424 937
Abstract:
The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
Control profile
James Kurnick from Needham, MA Get Report